Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia
Acute Myeloid Leukaemia (AML) is a rare but serious group of diseases that require critical decision-making for curative treatment. Over the past decade, scientific discovery has revealed dozens of prognostic gene mutations for AML while sequencing costs have plummeted. In this study, we compared th...
主要な著者: | Cressman, S, Karsan, A, Hogge, DE, McPherson, E, Bolbocean, C, Regier, DA, Peacock, SJ |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Wiley
2016
|
類似資料
-
Quality of life and socioeconomic indicators associated with survival of myeloid leukemias in Canada
著者:: Sonya Cressman, 等
出版事項: (2020-07-01) -
Acute Myeloid Leukaemia with Plasmacytosis
著者:: Yasmin Akhtar, Saqib Qayyum Ahmad, Shahid Jamal
出版事項: (2016-12-01) -
Exploring the acute myeloid leukaemias
著者:: TB Thapa
出版事項: (2013-10-01) -
Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
著者:: Eden, O, 等
出版事項: (1998) -
Acute myeloid leukaemia with aberrant expression of pancytokeratin: A diagnostic pitfall
著者:: Yasin Dhonye, 等
出版事項: (2023-02-01)